Delving into the Latest Updates on Dolorgiet GmbH & Co. KG with Synapse

Overview

Basic Info

Introduction

Dolorgiet is a privately-owned corporation based in Sankt Augustin, Germany, specializing in the production of pharmaceutical raw materials. Established in 1985, the company is currently led by co-CEOs Giuseppe Nardi and Peter Theiss.

In this three-armed dose-finding trial 3 AK 3012 topical formulations shall be investigated with respect to safety and efficacy in order to identify the optimal concentration in the topical formulation.
The main objective of the trial is to determine the optimal concentration of the active agent in the topical formulation as quantified by the change of the number of skin alterations in pre-defined areas in a time period from inclusion in the trial until the end of treatment (3 months) or prior complete healing.

Start Date01 Dec 2012

Sponsor / Collaborator

Dolorgiet GmbH & Co. KG

[+2]

100 Clinical Results associated with Dolorgiet GmbH & Co. KG

Login to view more data

0 Patents (Medical) associated with Dolorgiet GmbH & Co. KG

Login to view more data

100 Deals associated with Dolorgiet GmbH & Co. KG

Login to view more data

100 Translational Medicine associated with Dolorgiet GmbH & Co. KG

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Jan 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data